Sociedad Química y Minera de Chile S.A.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SQM research report →
Range $71 – $104
Price Chart
About the company
Sociedad Química y Minera de Chile S. A. (SQM) specializes in the production and global distribution of a diverse range of items, including advanced plant nutrients, various iodine and lithium derivatives, potassium chloride, potassium sulfate, and a selection of industrial chemicals.
- CEO
- Ricardo Ramos Rodríguez
- IPO
- 1993
- Employees
- 7,739
- HQ
- Santiago, SA, CL
AI snapshot
Six angles, distilled from the data.
The stock remains in a deep corrective regime, trading well below its 200-day average after a long slide from the 52-week high. It is still closer to the yearly low than the peak, which keeps the chart in repair mode rather than a confirmed trend reversal.
Street sentiment is cautious but not broken: consensus sits at Hold, while the average target of 88.2 is well above the last close. Recent action has been mixed, with upgrades from JPMorgan and Citigroup offset by several target cuts, suggesting analysts see upside but not a clean rerating yet.
The earnings backdrop is uneven. SQM has beaten only 1 of the last 7 quarters, but the next-year EPS view rises to 6.5223 from a 4.86 TTM base. Shareholders should watch whether lithium and specialty chemicals can sustain margin recovery after the latest miss-prone stretch.
No notable insider buying or selling in recent quarters. The only listed items are 10% owner records from 2016 marked as other transactions, with no discretionary purchase or sale signal in the recent period.
Profitability is solid, with a 42.2% gross margin, 38.72% operating margin, and 20.62% net margin. Growth is still strong, with revenue up 136.7% year over year and earnings up 646.4%, while free cash flow reached 2.19 billion on 2025 results.
SQM stands out for scale in lithium, iodine, and specialty fertilizers, but the market is discounting that mix because of volatility in the cycle. At 10.63x earnings, it trades at a restrained multiple for a materials name with strong cash generation and a premium target range above the current quote.
Similar companies
Peers in the same neighborhood.
- Market Cap
- $13.42B
- P/E
- 7.80
- Fwd P/E
- 6.42
- PEG
- 0.03
- P/S
- 1.78
- P/B
- 2.06
- EV/EBITDA
- 3.31
- Div Yield
- 4.87%
- Gross Margin
- 45.02%
- Op Margin
- 42.18%
- Net Margin
- 22.80%
- ROE
- 28.65%
- ROIC
- 13.61%
Latest fiscal year · YoY change
- Revenue
- $4.57B+0.9%
- Gross Profit
- $1.34B+0.9%
- Op Income
- $1.13B
- Net Income
- $587.21M+245.2%
- EPS
- $2.06+245.1%
- OCF Growth
- +3.1%
- FCF Growth
- +44.5%
- 52W High
- $98.00
- 52W Low
- $46.78
- 50D MA
- $60.98
- 200D MA
- $73.73
- Beta
- 1.02
- RSI (14)
- 26
- Avg Volume
- 976.81K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
SQM said Q3 demand stayed solid across lithium, iodine and specialty fertilizers, while lower lithium prices and softer fertilizer volumes remained the key near-term pressure points.· November 18, 2026
- SQM said net income for the first 3 quarters of 2026 was close to $1.6 billion, almost 4x the same period in 2025.
- Lithium demand remains strong in management’s view; they still expect about 30% global demand growth in 2026 and see 2027 demand growth of 15% to 20%.
- Management said lithium prices are below mid-year levels, but they expect prices to rise in the near future as demand stays ahead of new supply incentives.
- Novandino produced about 75,000 metric tons in Q3 and expects about 290,000 tons for 2026, with a little over 300,000 targeted for 2027.
- Specialty Plant Nutrition volumes were pressured by higher fertilizer prices, so full-year sales volume growth was revised to about 5% above last year.
SQM reported close to $1.6 billion in net income during the first 3 quarters of 2026, almost 4x higher than the same period in 2025. On lithium, management said global demand could grow by approximately 30% in 2026 and that 2027 demand could reach about 2.5 million metric tons, implying 15% to 20% growth. Novandino reported Q3 production of close to 75,000 metric tons, expects about 290,000 metric tons for 2026, and a little over 300,000 for 2027. For lithium sulfate, Carlos Diaz said 2026 production should be 160,000, equivalent to about 80,000 as lithium carbonate, with a slight increase expected next year. Management also said CapEx for 2026 to 2028 remains planned at around $3 billion, with 2026 slightly below the average pace. For Specialty Plant Nutrition, full-year sales volume growth was revised to approximately 5% over last year. No quarterly revenue, EPS, or gross margin figures were stated in the transcript.
Ricardo Ramos struck an upbeat but disciplined tone, emphasizing solid performance across the core businesses and confidence in longer-term demand. On lithium, he highlighted growth from EV adoption, higher lithium content per vehicle, expansion beyond China, and battery energy storage, saying the market should surpass 3 million metric tons by 2030. He also said iodine demand remains healthy and that the company is keeping financial discipline while preserving a long-term view.
Gerardo Illanes mainly addressed capital allocation, saying CapEx for 2026 to 2028 remains unchanged at about $3 billion, or roughly $1 billion per year on average. He noted 2026 will be slightly lower than that average, but said projects are moving according to schedule and no changes have been made to the CapEx plan. No detailed margin, cash balance, or financing figures were provided on the call.
Analysts focused on lithium demand durability, inventories, prices, CapEx timing, and the mix between spodumene and hydroxide. Management said most of the 30% 2026 lithium demand growth is coming from end-use consumption rather than inventory building, and they see 2027 demand up 15% to 20%. On pricing, they acknowledged current prices are well below mid-year levels but said the market is still below the incentive price needed for new supply and they expect prices to rise in the near future. On CapEx, management said the spend schedule has not changed despite softer lithium prices, and on the International division they said the hydroxide ramp is progressing but the exact split between refinery feed and direct spodumene sales is still being planned.
Management believes lithium demand is still robust, with both EVs and BESS supporting growth and with demand becoming more geographically diversified. They also said current prices are below the level needed to incentivize new supply, which supports their view that prices should improve. In iodine and Specialty Plant Nutrition, the company described healthy market demand and ongoing commercial strength.
The biggest near-term risk is the recent decline in lithium prices, which management acknowledged is well below mid-year levels. Specialty Plant Nutrition volumes were pressured by higher fertilizer prices, prompting a full-year sales volume growth reset to about 5%. The International Lithium Division also still has uncertainty around the mix and timing of direct sales versus refinery ramp-up, and the company did not give a fixed answer on when prices or volumes will inflect.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 36.5%
- Shares Outstanding
- 285.64M
- Float Shares
- 104.33M
of shares held by institutions
328 13F filers
Congressional trading
Senate and House stock disclosures for SQM, newest first.
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Baillie Gifford & Co | 4.26M | ▼ 474.36K |
| Van Eck Associates Corp | 3.71M | ▲ 1.06M |
| Earnest Partners LLC | 2.07M | ▼ 34.00K |
| Blackrock, Inc. | 1.83M | ▼ 543.09K |
| Grantham, Mayo, Van Otterloo & Co. LLC | 1.39M | ▼ 219.98K |
| Robeco Institutional Asset Management B.V. | 1.34M | ▲ 350.57K |
| Goldman Sachs Group Inc | 1.20M | ▲ 677.26K |
| Mirae Asset Global Etfs Holdings Ltd. | 1.02M | ▼ 168.06K |
| Renaissance Technologies LLC | 1.02M | ▲ 238.92K |
| Morgan Stanley | 943.16K | ▲ 277.67K |
| D. E. Shaw & Co., Inc. | 908.08K | ▼ 41.69K |
| Arrowstreet Capital, Limited Partnership | 773.62K | ▲ 770.75K |
Held by 159 ETFs
Biggest fund positions in SQM by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 28, 16 | SailingStone Capital Partners LLC | other | 0 |
| Mar 28, 16 | SailingStone Capital Partners LLC | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our SQM coverage
Recent articles, reports, and earnings notes.

SQM’s quiet rally says the lithium rebound may be more real than skeptics think
SQM’s latest move looks less like a random bounce and more like the market getting ahead of a better lithium tape. Chile’s lithium export value nearly tripling in the first half of 2026 gives that rally a fundamental backbone skeptics have been missing.

Best Lithium Stocks for September 2026: 7 Recovery Plays
A seven-stock countdown spanning lithium producers, chemical processors, brine developers and hard-rock projects, with Sigma, Standard Lithium and Lithium Americas among the lower-ranked names.
Want a deeper read on SQM?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
SQM Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into SQM (SQM)
prnewswire.com · Nov 19
Sociedad Química y Minera de Chile Stock Beaten Down Due To External Factors
seekingalpha.com · Nov 19
Sociedad Química y Minera de Chile: 3 Key Takeaways for Long-Term Investors
fool.com · Nov 18
What Sociedad Quimica y Minera (SQM) Said on Its Q3 Earnings Call
marketbeat.com · Nov 18
Sociedad Química y Minera de Chile S.A. (SQM) Q3 2026 Earnings Call Transcript
seekingalpha.com · Nov 18
Sociedad Química y Minera de Chile: Down 22% But I'm Buying At 7x Forward Earnings
seekingalpha.com · Nov 16
These 2 Basic Materials Stocks Could Beat Earnings: Why They Should Be on Your Radar
zacks.com · Oct 6
Sociedad Quimica y Minera de Chile: Staying On The Sidelines
seekingalpha.com · Aug 28
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
AI analysis · Last refreshed November 18, 2026 · Live quote · Not investment advice